-
-
-
-
-
-
-
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Epidiolex® (cannabidiol oral solution) in Lennox-Gastaut
-
-
-
-
-
-
-
GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents
-
-
-
-
-
-
-
Pre-Open Movers 12/06: (MDGL) (AVAV) (DVA) Higher; (PXS) (FRED) (TROX) Lower (more...)
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

